CareNavIQ

Every billing code / Treatments and drugs

Injections and Infusions (nononcologic)

1,254 codes, page 2 of 7.

Injection - Immune Globulin 7

CodeNameStatusHospitals with prices
HCPCS J2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)Current code32 hospitals
HCPCS J2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)Current code46 hospitals
HCPCS J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iuCurrent code42 hospitals
HCPCS J2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iuCurrent code31 hospitals
HCPCS J7504Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mgCurrent code36 hospitals
HCPCS J7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mgCurrent code36 hospitals
HCPCS Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)Current codenone yet

Injection - Immunomodulator 24

CodeNameStatusHospitals with prices
HCPCS C9038Injection, mogamulizumab-kpkc, 1 mgRetired codenone yet
HCPCS C9044Injection, cemiplimab-rwlc, 1 mgRetired codenone yet
HCPCS C9157Injection, tofersen, 1 mgRetired code10 hospitals
HCPCS J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)Current code46 hospitals
HCPCS J0256Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mgCurrent code44 hospitals
HCPCS J0257Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mgCurrent code38 hospitals
HCPCS J0485Injection, belatacept, 1 mgCurrent code39 hospitals
HCPCS J0596Injection, c1 esterase inhibitor (recombinant), ruconest, 10 unitsCurrent code28 hospitals
HCPCS J0597Injection, c-1 esterase inhibitor (human), berinert, 10 unitsCurrent code42 hospitals
HCPCS J0598Injection, c-1 esterase inhibitor (human), cinryze, 10 unitsCurrent code35 hospitals
HCPCS J0599Injection, c-1 esterase inhibitor (human), (haegarda), 10 unitsCurrent code26 hospitals
HCPCS J1595Injection, glatiramer acetate, 20 mgCurrent code32 hospitals
HCPCS J1600Injection, gold sodium thiomalate, up to 50 mgCurrent code16 hospitals
HCPCS J1744Injection, icatibant, 1 mgCurrent code26 hospitals
HCPCS J1826Injection, interferon beta-1a, 30 mcgCurrent code28 hospitals
HCPCS J1830Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)Current code26 hospitals
HCPCS J2793Injection, rilonacept, 1 mgCurrent code27 hospitals
HCPCS J2910Injection, aurothioglucose, up to 50 mgRetired code17 hospitals
HCPCS J7501Azathioprine, parenteral, 100 mgCurrent code35 hospitals
HCPCS J7516Injection, cyclosporine, 250 mgCurrent code32 hospitals
HCPCS J7519Injection, mycophenolate mofetil, 10 mgCurrent code38 hospitals
HCPCS J7525Tacrolimus, parenteral, 5 mgCurrent code41 hospitals
HCPCS J9331Injection, sirolimus protein-bound particles, 1 mgCurrent code33 hospitals
HCPCS Q3027Injection, interferon beta-1a, 1 mcg for intramuscular useCurrent code33 hospitals

Injection - Macular Degeneration 9

CodeNameStatusHospitals with prices
HCPCS C9097Inj, faricimab-svoa, 0.1 mgRetired code1 hospital
HCPCS C9161Injection, aflibercept hd, 1 mgRetired code22 hospitals
HCPCS C9162Injection, avacincaptad pegol, 0.1 mgRetired code22 hospitals
HCPCS J0177Injection, aflibercept hd, 1 mgCurrent code28 hospitals
HCPCS J0178Injection, aflibercept, 1 mgCurrent code28 hospitals
HCPCS J0179Injection, brolucizumab-dbll, 1 mgCurrent code28 hospitals
HCPCS J2777Injection, faricimab-svoa, 0.1 mgCurrent code28 hospitals
HCPCS J2782Injection, avacincaptad pegol, 0.1 mgCurrent code28 hospitals
HCPCS Q5147Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mgCurrent code27 hospitals

Injection - Monoclonal Antibodies 148

CodeNameStatusHospitals with prices
CPT 90378Injection - Monoclonal AntibodiesCurrent code36 hospitals
CPT 96380Injection - Monoclonal AntibodiesCurrent code25 hospitals
CPT 96381Injection - Monoclonal AntibodiesCurrent code23 hospitals
HCPCS C9015Injection, c-1 esterase inhibitor (human), haegarda, 10 unitsRetired code1 hospital
HCPCS C9026Injection, vedolizumab, 1 mgRetired codenone yet
HCPCS C9029Injection, guselkumab, 1 mgRetired code1 hospital
HCPCS C9040Injection, fremanezumab-vfrm, 1mgRetired codenone yet
HCPCS C9047Injection, caplacizumab-yhdp, 1 mgCurrent code29 hospitals
HCPCS C9050Injection, emapalumab-lzsg, 1 mgRetired codenone yet
HCPCS C9052Injection, ravulizumab-cwvz, 10 mgRetired codenone yet
HCPCS C9053Injection, crizanlizumab-tmca, 1 mgRetired codenone yet
HCPCS C9061Injection, teprotumumab-trbw, 10 mgRetired code1 hospital
HCPCS C9062Injection, daratumumab 10 mg and hyaluronidase-fihjRetired code17 hospitals
HCPCS C9063Injection, eptinezumab-jjmr, 1 mgRetired code1 hospital
HCPCS C9079Injection, evinacumab-dgnb, 5 mgRetired code1 hospital
HCPCS C9086Injection, anifrolumab-fnia, 1 mgRetired code1 hospital
HCPCS C9093Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mgRetired code2 hospitals
HCPCS C9094Inj, sutimlimab-jome, 10 mgRetired code1 hospital
HCPCS C9149Injection, teplizumab-mzwv, 5 mcgRetired code17 hospitals
HCPCS C9166Injection, secukinumab, intravenous, 1 mgRetired code10 hospitals
HCPCS C9168Injection, mirikizumab-mrkz, 1 mgRetired code10 hospitals
HCPCS C9304Injection, marstacimab-hncq, 0.5 mgRetired code11 hospitals
HCPCS C9305Injection, nipocalimab-aahu, 3 mgRetired code9 hospitals
HCPCS C9466Injection, benralizumab, 1 mgRetired code1 hospital
HCPCS C9473Injection, mepolizumab, 1 mgRetired code1 hospital
HCPCS C9487Ustekinumab, for intravenous injection, 1 mgRetired code1 hospital
HCPCS C9490Injection, bezlotoxumab, 10 mgRetired code1 hospital
HCPCS C9494Injection, ocrelizumab, 1 mgRetired code1 hospital
HCPCS J0130Injection abciximab, 10 mgCurrent code23 hospitals
HCPCS J0135Injection, adalimumab, 20 mgRetired code25 hospitals
HCPCS J0172Injection, aducanumab-avwa, 2 mgRetired code25 hospitals
HCPCS J0174Lecanemab-irmb, for intravenous injection, 1 mgCurrent code40 hospitals
HCPCS J0175Injection, donanemab-azbt, 2 mgCurrent code35 hospitals
HCPCS J0480Injection, basiliximab, 20 mgCurrent code29 hospitals
HCPCS J0490Injection, belimumab, 10 mgCurrent code44 hospitals
HCPCS J0491Injection, anifrolumab-fnia, 1 mgCurrent code41 hospitals
HCPCS J0517Injection, benralizumab, 1 mgCurrent code39 hospitals
HCPCS J0565Injection, bezlotoxumab, 10 mgCurrent code32 hospitals
HCPCS J0584Injection, burosumab-twza 1 mgCurrent code33 hospitals
HCPCS J0593Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)Current code28 hospitals
HCPCS J0638Injection, canakinumab, 1 mgCurrent code31 hospitals
HCPCS J0640Injection, leucovorin calcium, per 50 mgCurrent code39 hospitals
HCPCS J0791Injection, crizanlizumab-tmca, 5 mgCurrent code29 hospitals
HCPCS J0897Injection, denosumab, 1 mgCurrent code50 hospitals
HCPCS J1299Injection, eculizumab, 2 mgCurrent code41 hospitals
HCPCS J1300Injection, eculizumab, 10 mgRetired code28 hospitals
HCPCS J1302Injection, sutimlimab-jome, 10 mgCurrent code28 hospitals
HCPCS J1303Injection, ravulizumab-cwvz, 10 mgCurrent code43 hospitals
HCPCS J1305Injection, evinacumab-dgnb, 5mgCurrent code28 hospitals
HCPCS J1307Injection, crovalimab-akkz, 10 mgCurrent code28 hospitals
HCPCS J1628Injection, guselkumab, 1 mgCurrent code41 hospitals
HCPCS J1745Injection, infliximab, excludes biosimilar, 10 mgCurrent code48 hospitals
HCPCS J1746Injection, ibalizumab-uiyk, 10 mgCurrent code28 hospitals
HCPCS J1747Injection, spesolimab-sbzo, 1 mgCurrent code35 hospitals
HCPCS J1748Injection, infliximab-dyyb (zymfentra), 10 mgCurrent code22 hospitals
HCPCS J1823Injection, inebilizumab-cdon, 1 mgCurrent code28 hospitals
HCPCS J2182Injection, mepolizumab, 1 mgCurrent code42 hospitals
HCPCS J2267Injection, mirikizumab-mrkz, 1 mgCurrent code28 hospitals
HCPCS J2323Injection, natalizumab, 1 mgCurrent code44 hospitals
HCPCS J2327Injection, risankizumab-rzaa, intravenous, 1 mgCurrent code37 hospitals
HCPCS J2329Injection, ublituximab-xiiy, 1mgCurrent code36 hospitals
HCPCS J2350Injection, ocrelizumab, 1 mgCurrent code45 hospitals
HCPCS J2351Injection, ocrelizumab, 1 mg and hyaluronidase-ocsqCurrent code32 hospitals
HCPCS J2356Injection, tezepelumab-ekko, 1 mgCurrent code42 hospitals
HCPCS J2357Injection, omalizumab, 5 mgCurrent code43 hospitals
HCPCS J2778Injection, ranibizumab, 0.1 mgCurrent code28 hospitals
HCPCS J2779Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mgCurrent code28 hospitals
HCPCS J2786Injection, reslizumab, 1 mgCurrent code33 hospitals
HCPCS J2860Injection, siltuximab, 10 mgCurrent code28 hospitals
HCPCS J3031Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)Current code26 hospitals
HCPCS J3032Injection, eptinezumab-jjmr, 1 mgCurrent code45 hospitals
HCPCS J3111Injection, romosozumab-aqqg, 1 mgCurrent code44 hospitals
HCPCS J3241Injection, teprotumumab-trbw, 10 mgCurrent code42 hospitals
HCPCS J3245Injection, tildrakizumab, 1 mgCurrent code33 hospitals
HCPCS J3247Injection, secukinumab, intravenous, 1 mgCurrent code38 hospitals
HCPCS J3262Injection, tocilizumab, 1 mgCurrent code39 hospitals
HCPCS J3357Ustekinumab, for subcutaneous injection, 1 mgCurrent code37 hospitals
HCPCS J3358Ustekinumab, for intravenous injection, 1 mgCurrent code44 hospitals
HCPCS J3380Injection, vedolizumab, intravenous, 1 mgCurrent code47 hospitals
HCPCS J7170Injection, emicizumab-kxwh, 0.5 mgCurrent code34 hospitals
HCPCS J7172Injection, marstacimab-hncq, 0.5 mgCurrent code18 hospitals
HCPCS J7173Injection, concizumab-mtci, 0.5 mgCurrent code14 hospitals
HCPCS J7505Muromonab-cd3, parenteral, 5 mgRetired code15 hospitals
HCPCS J7513Daclizumab, parenteral, 25 mgRetired code16 hospitals
HCPCS J9210Injection, emapalumab-lzsg, 1 mgCurrent code29 hospitals
HCPCS J9332Injection, efgartigimod alfa-fcab, 2mgCurrent code41 hospitals
HCPCS J9333Injection, rozanolixizumab-noli, 1 mgCurrent code35 hospitals
HCPCS J9334Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfcCurrent code33 hospitals
HCPCS J9376Injection, pozelimab-bbfg, 1 mgCurrent code24 hospitals
HCPCS J9381Injection, teplizumab-mzwv, 5 mcgCurrent code29 hospitals
HCPCS M0220Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoringRetired code30 hospitals
HCPCS M0221Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergencyRetired code29 hospitals
HCPCS M0222Intravenous injection, bebtelovimab, includes injection and post administration monitoringRetired code31 hospitals
HCPCS M0223Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergencyRetired code25 hospitals
HCPCS M0224Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoringCurrent code28 hospitals
HCPCS M0235Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first doseCurrent code14 hospitals
HCPCS M0236Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second doseCurrent code14 hospitals
HCPCS M0237Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first doseCurrent code16 hospitals
HCPCS M0238Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second doseCurrent code16 hospitals
HCPCS M0239Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoringRetired code1 hospital
HCPCS M0240Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat dosesRetired code24 hospitals
HCPCS M0241Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat dosesRetired code24 hospitals
HCPCS M0243Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoringRetired code30 hospitals
HCPCS M0244Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergencyRetired code24 hospitals
HCPCS M0245Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoringRetired code30 hospitals
HCPCS M0246Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergencyRetired code24 hospitals
HCPCS M0247Intravenous infusion, sotrovimab, includes infusion and post administration monitoringRetired code29 hospitals
HCPCS M0248Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergencyRetired code24 hospitals
HCPCS M0249Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first doseCurrent code38 hospitals
HCPCS M0250Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second doseCurrent code35 hospitals
HCPCS Q0220Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mgRetired codenone yet
HCPCS Q0221Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mgRetired codenone yet
HCPCS Q0222Injection, bebtelovimab, 175 mgRetired code23 hospitals
HCPCS Q0224Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mgCurrent code29 hospitals
HCPCS Q0235Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mgCurrent codenone yet
HCPCS Q0237Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mgCurrent code2 hospitals
HCPCS Q0239Injection, bamlanivimab-xxxx, 700 mgRetired codenone yet
HCPCS Q0240Injection, casirivimab and imdevimab, 600 mgRetired code1 hospital
HCPCS Q0243Injection, casirivimab and imdevimab, 2400 mgRetired codenone yet
HCPCS Q0244Injection, casirivimab and imdevimab, 1200 mgRetired codenone yet
HCPCS Q0245Injection, bamlanivimab and etesevimab, 2100 mgRetired codenone yet
HCPCS Q0247Injection, sotrovimab, 500 mgRetired code20 hospitals
HCPCS Q0249Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mgCurrent code32 hospitals
HCPCS Q5099Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mgCurrent code24 hospitals
HCPCS Q5100Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mgCurrent code22 hospitals
HCPCS Q5102Injection, infliximab, biosimilar, 10 mgRetired codenone yet
HCPCS Q5103Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mgCurrent code46 hospitals
HCPCS Q5104Injection, infliximab-abda, biosimilar, (renflexis), 10 mgCurrent code44 hospitals
HCPCS Q5109Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mgRetired code9 hospitals
HCPCS Q5115Injection, rituximab-abbs, biosimilar, (truxima), 10 mgCurrent code46 hospitals
HCPCS Q5119Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mgCurrent code38 hospitals
HCPCS Q5121Injection, infliximab-axxq, biosimilar, (avsola), 10 mgCurrent code35 hospitals
HCPCS Q5124Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mgCurrent code28 hospitals
HCPCS Q5128Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mgCurrent code29 hospitals
HCPCS Q5131Injection, adalimumab-aacf (idacio), biosimilar, 20 mgRetired code9 hospitals
HCPCS Q5133Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mgCurrent code36 hospitals
HCPCS Q5135Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mgCurrent code35 hospitals
HCPCS Q5136Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mgCurrent code23 hospitals
HCPCS Q5137Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mgCurrent code6 hospitals
HCPCS Q5138Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mgCurrent code20 hospitals
HCPCS Q5151Injection, eculizumab-aagh (epysqli), biosimilar, 2 mgCurrent code17 hospitals
HCPCS Q5152Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mgCurrent code17 hospitals
HCPCS Q9979Injection, alemtuzumab, 1 mgRetired codenone yet
HCPCS Q9989Ustekinumab, for intravenous injection, 1 mgRetired code1 hospital
HCPCS Q9995Injection, emicizumab-kxwh, 0.5 mgRetired codenone yet
HCPCS Q9997Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mgCurrent code18 hospitals
HCPCS Q9998Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mgCurrent code22 hospitals
HCPCS Q9999Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mgCurrent code18 hospitals

Injection - Somatostatin 6

CodeNameStatusHospitals with prices
HCPCS C9454Injection, pasireotide long acting, 1 mgRetired codenone yet
HCPCS J1930Injection, lanreotide, 1 mgCurrent code33 hospitals
HCPCS J1932Injection, lanreotide, (cipla), 1 mgCurrent code35 hospitals
HCPCS J2353Injection, octreotide, depot form for intramuscular injection, 1 mgCurrent code43 hospitals
HCPCS J2354Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcgCurrent code45 hospitals
HCPCS J2502Injection, pasireotide long acting, 1 mgCurrent code28 hospitals

Injection - Tumor Necrosis Factor Blocker 6

CodeNameStatusHospitals with prices
HCPCS J0139Injection, adalimumab, 1 mgCurrent code25 hospitals
HCPCS J0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)Current code43 hospitals
HCPCS J1438Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)Current code29 hospitals
HCPCS J1602Injection, golimumab, 1 mg, for intravenous useCurrent code46 hospitals
HCPCS Q5132Injection, adalimumab-afzb (abrilada), biosimilar, 10 mgRetired codenone yet
HCPCS Q5140Injection, adalimumab-fkjp, biosimilar, 1 mgCurrent code25 hospitals